Literature DB >> 29589087

Imbalanced bone turnover markers and low bone mineral density in patients with osteonecrosis of the femoral head.

Lulu Tian1, Seung-Hoon Baek2,3, JinAn Jang3, Shin-Yoon Kim4,5,6.   

Abstract

PURPOSE: There have been few studies investigating the cumulative effect of individual factors related to bone metabolism on the systemic balance between bone formation and resorption in patients with osteonecrosis of the femoral head (ONFH). We investigated bone mineral density (BMD) of lumbar spine and bone turnover markers that reflect systemic bone metabolism.
METHODS: Two-hundred twenty patients with ONFH were matched to 220 healthy subjects according to age, gender, and body mass index. ONFH patients were divided into steroid-induced (18%), alcoholic (21%), and idiopathic ONFH (61%) and subgroup analysis was performed to exclude the effect of steroid and malnutrition on bone metabolism. We compared lumbar spine bone mineral density (BMD) between groups and measured serum bone-specific alkaline phosphatase (BALP) and urinary deoxypyridinoline/creatinine (Dpd/Cr) ratio.
RESULTS: Logistic regression analysis revealed low spine BMD was significantly associated with each subgroup of ONFH when compared with that of the control group (odds ratio of 2.27, 4.24, and 1.86 in alcoholic, steroid, and idiopathic ONFH, respectively). The mean value of serum BALP (27.02 U/L) was within the normal reference range while average urine Dpd/Cr ratio (6.24 nM/mM) increased in ONFH group when compared with respective reference range.
CONCLUSION: Spine BMD decreased and urinary Dpd/Cr ratio increased in patients with non-traumatic ONFH. Further studies will be necessary to identify whether non-traumatic ONFH is merely a regional disease confined to the femoral head or may affect systemic bone metabolism.

Entities:  

Keywords:  Bone mineral density; Bone turnover makers; Bone-specific alkaline phosphatase; Deoxypyridinoline/creatinine ratio; Osteonecrosis of femoral head

Mesh:

Substances:

Year:  2018        PMID: 29589087     DOI: 10.1007/s00264-018-3902-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  23 in total

1.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

2.  Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis.

Authors:  Je-Ken Chang; Mei-Ling Ho; Ching-Hua Yeh; Chung-Hwan Chen; Gwo-Jaw Wang
Journal:  Clin Orthop Relat Res       Date:  2006-12       Impact factor: 4.176

Review 3.  Fat embolism and osteonecrosis.

Authors:  J P Jones
Journal:  Orthop Clin North Am       Date:  1985-10       Impact factor: 2.472

Review 4.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

Review 5.  Alcohol and bone: review of dose effects and mechanisms.

Authors:  D B Maurel; N Boisseau; C L Benhamou; C Jaffre
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

6.  Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse.

Authors:  P Hernigou; F Beaujean
Journal:  J Bone Joint Surg Am       Date:  1997-07       Impact factor: 5.284

7.  Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head.

Authors:  S Radke; A Battmann; S Jatzke; J Eulert; F Jakob; N Schütze
Journal:  J Orthop Res       Date:  2006-05       Impact factor: 3.494

8.  Influence of factors regulating bone formation and remodeling on bone quality in osteonecrosis of the femoral head.

Authors:  Markus Tingart; Johannes Beckmann; Alfred Opolka; Maiko Matsuura; Oliver Wiech; Joachim Grifka; Susanne Grässel
Journal:  Calcif Tissue Int       Date:  2008-03-05       Impact factor: 4.333

Review 9.  Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors.

Authors:  M A Mont; L C Jones; T A Einhorn; D S Hungerford; A H Reddi
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

Review 10.  Bone turnover markers: understanding their value in clinical trials and clinical practice.

Authors:  R Civitelli; R Armamento-Villareal; N Napoli
Journal:  Osteoporos Int       Date:  2009-02-04       Impact factor: 4.507

View more
  9 in total

1.  Hip osteonecrosis: stem cells for life or behead and arthroplasty?

Authors:  Philippe Hernigou; Gildasio Daltro; Jacques Hernigou
Journal:  Int Orthop       Date:  2018-06-08       Impact factor: 3.075

2.  [Predictive effect of femoral neck strength composite indexes on femoral head collapse in non-traumatic osteonecrosis of femoral head].

Authors:  Tianye Lin; Peng Yang; Kaishen Cai; Ziqi Li; Fengxiang Pang; Qingwen Zhang; Wei He; Qiushi Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-08-15

3.  Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Authors:  Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

4.  Upregulating MicroRNA-410 or Downregulating Wnt-11 Increases Osteoblasts and Reduces Osteoclasts to Alleviate Osteonecrosis of the Femoral Head.

Authors:  Yukun Yin; Lixiang Ding; Yu Hou; Haoran Jiang; Ji Zhang; Zhong Dai; Genai Zhang
Journal:  Nanoscale Res Lett       Date:  2019-12-18       Impact factor: 5.418

5.  Hip pathologies in mucopolysaccharidosis type III.

Authors:  Sandra Rafaela Breyer; Eik Vettorazzi; Leonie Schmitz; Amit Gulati; Katharina Maria von Cossel; Alexander Spiro; Martin Rupprecht; Ralf Stuecker; Nicole Maria Muschol
Journal:  J Orthop Surg Res       Date:  2021-03-19       Impact factor: 2.359

6.  Composite indices of femoral neck strength predicts the collapse of steroid-associated osteonecrosis of the femoral head: a retrospective study.

Authors:  Tianye Lin; Kaishen Cai; Peng Yang; Shana WuRi; Weijian Chen; Pan Deng; Ziqi Li; Zhenqiu Chen; Wei He; Qingwen Zhang; Qiushi Wei
Journal:  BMC Musculoskelet Disord       Date:  2022-07-28       Impact factor: 2.562

7.  PFKP and GPC6 Variants Were Correlated with Alcohol-Induced Femoral Head Necrosis Risk in the Chinese Han Population.

Authors:  Chang Liu; Xuan Liu; Xiaolin Li
Journal:  Pharmgenomics Pers Med       Date:  2022-09-09

8.  IL-15 deficiency alleviates steroid-induced osteonecrosis of the femoral head by impact osteoclasts via RANKL-RANK-OPG system.

Authors:  Zubin Zhou; Yiwei Lin; Chenhao Pan; Nan Wang; Lihui Zhou; Haojie Shan; Youshui Gao; Xiaowei Yu
Journal:  Immun Ageing       Date:  2020-06-12       Impact factor: 6.400

9.  Treatment of pre-collapse non-traumatic osteonecrosis of the femoral head through Orthopdische Chirurgie München approach combined with autologous bone mixed with β-tricalcium phosphate porous bioceramic bone graft: a retrospective study of mid-term results.

Authors:  Dawei Liang; Jia Pei; Leilei Zhang; Haonan Ling; Youwen Liu; Xiantao Chen
Journal:  J Orthop Surg Res       Date:  2021-08-12       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.